Mutations in Potassium Channel Kir2.6 Cause Susceptibility to Thyrotoxic Hypokalemic Periodic Paralysis

Cell

Volumn 140, Issue 1, 2010, Pages 88-98

  Ryan, Devon P ^a,b   Dias da Silva, Magnus R ^b   Soong, Tuck Wah ^c,g   Fontaine, Bertrand ^d   Donaldson, Matt R ^b   Kung, Annie W C ^e   Jongjaroenprasert, Wallaya ^f   Liang, Mui Cheng ^g   Khoo, Daphne H C ⁱ   Cheah, Jin Seng ^h   Ho, Su Chin ⁱ   Bernstein, Harold S ^a   Maciel, Rui M B ^j   Brown Jr , Robert H ^k   Ptáček, Louis J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^d INSERM   (France)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f MAHIDOL UNIVERSITY   (Thailand)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^h Dept Medicine Endocrinol Diabet   (Singapore)

ⁱ SINGAPORE GENERAL HOSPITAL   (Singapore)

^j FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

HUMDISEASE; PROTEINS; SIGNALING

Indexed keywords

INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.6; LIOTHYRONINE; MUTANT PROTEIN; THYROID HORMONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EMBRYO; FRAMESHIFT MUTATION; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; HYPOKALEMIC PERIODIC PARALYSIS; MAMMAL CELL; MEMBRANE DEPOLARIZATION; MISSENSE MUTATION; MOUSE; MUSCLE FIBER MEMBRANE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POTASSIUM CHANNELOPATHY; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; THYROTOXICOSIS; TRANSCRIPTION REGULATION; WILD TYPE;

MAMMALIA;

EID: 73349132366     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2009.12.024     Document Type: Article

References (35)

1. Abraham M.R., Jahangir A., Alekseev A.E., and Terzic A. Channelopathies of inwardly rectifying potassium channels. FASEB J. 13 (1999) 1901-1910
2. Bailey J.A., Yavor A.M., Massa H.F., Trask B.J., and Eichler E.E. Segmental duplications: organization and impact within the current human genome project assembly. Genome Res. 11 (2001) 1005-1017
3. Bassett J.H., Harvey C.B., and Williams G.R. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol. Cell. Endocrinol. 213 (2003) 1-11
4. Bulman D.E., Scoggan K.A., van Oene M.D., Nicolle M.W., Hahn A.F., Tollar L.L., and Ebers G.C. A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 53 (1999) 1932-1936
5. Donaldson M.R., Jensen J.L., Tristani-Firouzi M., Tawil R., Bendahhou S., Suarez W.A., Cobo A.M., Poza J.J., Behr E., Wagstaff J., et al. PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome. Neurology 60 (2003) 1811-1816
6. Eichler E.E., Clark R.A., and She X. An assessment of the sequence gaps: unfinished business in a finished human genome. Nat. Rev. Genet. 5 (2004) 345-354
7. Hugnot J.P., Pedeutour F., Le Calvez C., Grosgeorge J., Passage E., Fontes M., and Lazdunski M. The human inward rectifying K+ channel Kir 2.2 (KCNJ12) gene: gene structure, assignment to chromosome 17p11.1, and identification of a simple tandem repeat polymorphism. Genomics 39 (1997) 113-116
8. Karle C.A., Zitron E., Zhang W., Wendt-Nordahl G., Kathöfer S., Thomas D., Gut B., Scholz E., Vahl C.F., Katus H.A., and Kiehn J. Human cardiac inwardly-rectifying K+ channel Kir(2.1b) is inhibited by direct protein kinase C-dependent regulation in human isolated cardiomyocytes and in an expression system. Circulation 106 (2002) 1493-1499
9. Kavok N.S., Krasilnikova O.A., and Babenko N.A. Thyroxine signal transduction in liver cells involves phospholipase C and phospholipase D activation. Genomic independent action of thyroid hormone. BMC Cell Biol. 2 (2001) 5
10. Kelley D.E., Gharib H., Kennedy F.P., Duda Jr. R.J., and McManis P.G. Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings. Arch. Intern. Med. 149 (1989) 2597-2600
11. Krapivinsky G., Medina I., Eng L., Krapivinsky L., Yang Y., and Clapham D.E. A novel inward rectifier K+ channel with unique pore properties. Neuron 20 (1998) 995-1005
12. Kung A.W. Thyrotoxic Periodic Paralysis. In: Wass J.A.H., Shalet S.M., and Gale E.A.M. (Eds). Oxford Textbook of Endocrinology and Diabetes (2002), Oxford University Press, Oxford 427-429
13. Kung A.W. Clinical review: thyrotoxic periodic paralysis: a diagnostic challenge. J. Clin. Endocrinol. Metab. 91 (2006) 2490-2495
14. Le Bouter S., Demolombe S., Chambellan A., Bellocq C., Aimond F., Toumaniantz G., Lande G., Siavoshian S., Baró I., Pond A.L., et al. Microarray analysis reveals complex remodeling of cardiac ion channel expression with altered thyroid status: relation to cellular and integrated electrophysiology. Circ. Res. 92 (2003) 234-242
15. Leonoudakis D., Conti L.R., Anderson S., Radeke C.M., McGuire L.M., Adams M.E., Froehner S.C., Yates III J.R., and Vandenberg C.A. Protein trafficking and anchoring complexes revealed by proteomic analysis of inward rectifier potassium channel (Kir2.x)-associated proteins. J. Biol. Chem. 279 (2004) 22331-22346
16. Leonoudakis D., Conti L.R., Radeke C.M., McGuire L.M., and Vandenberg C.A. A multiprotein trafficking complex composed of SAP97, CASK, Veli, and Mint1 is associated with inward rectifier Kir2 potassium channels. J. Biol. Chem. 279 (2004) 19051-19063
17. Lin H.Y., Davis F.B., Gordinier J.K., Martino L.J., and Davis P.J. Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells. Am. J. Physiol. 276 (1999) C1014-C1024
18. Lopes C.M., Zhang H., Rohacs T., Jin T., Yang J., and Logothetis D.E. Alterations in conserved Kir channel-PIP2 interactions underlie channelopathies. Neuron 34 (2002) 933-944
19. Lu Z. Mechanism of rectification in inward-rectifier K+ channels. Annu. Rev. Physiol. 66 (2004) 103-129
20. Namba N., Inagaki N., Gonoi T., Seino Y., and Seino S. Kir2.2v: a possible negative regulator of the inwardly rectifying K+ channel Kir2.2. FEBS Lett. 386 (1996) 211-214
21. Namba N., Mori R., Tanaka H., Kondo I., Narahara K., and Seino Y. The inwardly rectifying potassium channel subunit Kir2.2v (KCNJN1) maps to 17p11.2->p11.1. Cytogenet. Cell Genet. 79 (1997) 85-87
22. Nemzek J.A., Kruger J.M., Walshaw R., and Hauptman J.G. Acute onset of hypokalemia and muscular weakness in four hyperthyroid cats. J. Am. Vet. Med. Assoc. 205 (1994) 65-68
23. Nichols C.G., and Lopatin A.N. Inward rectifier potassium channels. Annu. Rev. Physiol. 59 (1997) 171-191
24. Plaster N.M., Tawil R., Tristani-Firouzi M., Canún S., Bendahhou S., Tsunoda A., Donaldson M.R., Iannaccone S.T., Brunt E., Barohn R., et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105 (2001) 511-519
25. Preisig-Müller R., Schlichthörl G., Goerge T., Heinen S., Brüggemann A., Rajan S., Derst C., Veh R.W., and Daut J. Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome. Proc. Natl. Acad. Sci. USA 99 (2002) 7774-7779
26. Ptácek L.J., Tawil R., Griggs R.C., Engel A.G., Layzer R.B., Kwieciński H., McManis P.G., Santiago L., Moore M., Fouad G., et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77 (1994) 863-868
27. Ryan D.P., and Ptácek L.J. Ion channel disorders. In: Rosenberg R.N., DiMauro S., Paulson H.L., Ptácek L.J., and Nestler E.J. (Eds). The Molecular and Genetic Basis of Neurologic and Psychiatric Disease (2007), Lippincott Williams & Wilkins, Philadelphia 550-568
28. Silva M.R., Chiamolera M.I., Kasamatsu T.S., Cerutti J.M., and Maciel R.M. Thyrotoxic hypokalemic periodic paralysis, an endocrine emergency: clinical and genetic features in 25 patients. Arq. Bras. Endocrinol. Metabol. 48 (2004) 196-215
29. Soom M., Schönherr R., Kubo Y., Kirsch C., Klinger R., and Heinemann S.H. Multiple PIP2 binding sites in Kir2.1 inwardly rectifying potassium channels. FEBS Lett. 490 (2001) 49-53
30. Takahashi N., Morishige K., Jahangir A., Yamada M., Findlay I., Koyama H., and Kurachi Y. Molecular cloning and functional expression of cDNA encoding a second class of inward rectifier potassium channels in the mouse brain. J. Biol. Chem. 269 (1994) 23274-23279
31. Tinker A., Jan Y.N., and Jan L.Y. Regions responsible for the assembly of inwardly rectifying potassium channels. Cell 87 (1996) 857-868
32. Wible B.A., De Biasi M., Majumder K., Taglialatela M., and Brown A.M. Cloning and functional expression of an inwardly rectifying K+ channel from human atrium. Circ. Res. 76 (1995) 343-350
33. Zaritsky J.J., Eckman D.M., Wellman G.C., Nelson M.T., and Schwarz T.L. Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K(+) current in K(+)-mediated vasodilation. Circ. Res. 87 (2000) 160-166
34. Zaritsky J.J., Redell J.B., Tempel B.L., and Schwarz T.L. The consequences of disrupting cardiac inwardly rectifying K(+) current (I(K1)) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes. J. Physiol. 533 (2001) 697-710
35. Zobel C., Cho H.C., Nguyen T.T., Pekhletski R., Diaz R.J., Wilson G.J., and Backx P.H. Molecular dissection of the inward rectifier potassium current (IK1) in rabbit cardiomyocytes: evidence for heteromeric co-assembly of Kir2.1 and Kir2.2. J. Physiol. 550 (2003) 365-372